Welcome : Guest

Revenio Group Oyj (Finland) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Revenio Group Oyj, which is principally involved in the Manufacture of Medical Instruments. Illustrated with 6 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-33643
Price: $300
Company Type: Public
Pages: 8
Date: September 2016
Market Data Tables: 6

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Revenio Group Oyj’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Finland, Other Europe, and Others......3
Table 2: Revenio Group Oyj’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Finland, Rest of Europe and Others......4
Glaucoma......5
Table 3: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......5
Ophthalmology......6
Table 4: Ophthalmology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Ophthalmic pharmaceuticals, Surgical, and Vision Care......6
Table 5: Ophthalmology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cataract & Vitreoretinal Surgery, Ophthalmic Lasers, and Vision Care......7
Osteoporosis......8
Table 6: Market Shares of Leading Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc. (AMGN), Eli Lilly And Co (LLY), Merck & Co., Inc. (MRK), Novartis AG (NVS), Sanofi SA (SNY), Warner Chilcott Plc (WCRX), and Others......8